(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
'Wow!' The eye surgery marathon that restored sight for some South Africans - 2Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- 3Step by step instructions to Choose the Right Auto Crash Legal counselor for Your Case
- 4Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- 5Don’t let food poisoning crash your Thanksgiving dinner
- What do teens and tweens want for the holidays? E-bikes, gift cards and lip tints.
- Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
- Living in the dark: Gaza’s struggle for electricity
- The Main 20 Gaming Control center Ever
- Extraordinary Picks for Home Apparatuses: Making Life Simpler
- 6 Well known Nissan Vehicles in the U.S.
- They died 'doing what they loved': The stories of workers in their 80s who died on the job
- Consumer outlook on UK economy falls to two-year low
- UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
